Try our Advanced Search for more refined results

Investors Spar Over Ionis Director Pay Suit Deal In Chancery

By Rose Krebs (August 30, 2022, 4:17 PM EDT) -- An Ionis Pharmaceuticals Inc. investor is seeking to delay a Delaware Chancery Court hearing to consider a proposed deal to end a suit filed over allegedly excessive company director pay, after being accused by settling parties' counsel of repeatedly trying to derail the settlement process....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!